Physiology and endocrinology of hot flashes in prostate cancer

American Journal of Men's Health

Volumn 1, Issue 1, 2007, Pages 8-17

  Engstrom, Christine A ^a,b,d   Kasper, Christine E ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA Headquarters   (United States)

^d AOCN   (United States)

Author keywords

Androgen ablation; Hot flashes; Physiology; Prostate cancer

Indexed keywords

ANTIANDROGEN;

ANIMAL; HISTOLOGY; HOT FLUSH; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVIEW; TESTIS; THERMOREGULATION;

ANDROGEN ANTAGONISTS; ANIMALS; BODY TEMPERATURE REGULATION; HOT FLASHES; HUMANS; HYPOTHALAMUS; MALE; PITUITARY GLAND; PROSTATIC NEOPLASMS; TESTIS;

EID: 47149091828     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988306294162     Document Type: Review

References (68)

1. Ahles, T. A., Herndon, J. E., II, Small, E. J., Vogelzang, N. J., Kornblith, A. B., Ratain, M. J., et al. (2004). Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: Results of Intergroup O159/Cancer and Leukemia Group B 9480. Cancer, 101 (10), 2202-2208.
2. Altwein, J., Ekman, P., Barry, M., Biermann, C., Carlsson, P., Fossa, S., et al. (1997). How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology, 49 (4A, Suppl.), 66- 76.
3. American Cancer Society. (2006). Cancer facts and figures 2006. Retrieved March 7, 2006, from http://www.cancer.org/downloads/STT/ CAFF2006PWSecured.pdf
4. Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R. O., Storme, G., et al. (1997). Improved survival in patients with locally advanced prostate cancer treated with radio-therapy and goserelin. New England Journal of Medicine, 337 (5), 295-300.
5. Bressler, L. R., Murphy, C. M., Shevrin, D. H., & Warren, R. F. (1993). Use of clonidine to treat hot flashes secondary to leuprolide or goserelin. Annals of Pharmacotherapy, 27 (2), 182- 185.
6. Carmel, P. W., Arani, S., & Ferrin, M. (1976). Pituitary stalk portal blood collection in rhesus monkeys: Evidence of pulsatile release of gonadotropin releasing hormone (GnRH). Endocrinology, 99, 243-243.
7. Carpenter, J. S. (2001). The Hot Flash Related Daily Interference Scale: A tool for assessing the impact of hot flashes on quality of life following breast cancer. Journal of Pain and Symptom Management, 22 (6), 979-989.
8. Carpenter, J. S., Andrykowski, M. A., Freedman, R. R., & Munn, R. (1999). Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause, 6 (3), 209-215.
9. Carpenter, J. S., Gautam, S., Freedman, R. R., & Andrykowski, M. (2001). Circadian rhythm of objectively recorded hot flashes in postmenopausal breast cancer survivors. Menopause, 8 (3), 181-188.
10. Carpenter, J. S., Gilchrist, J. M., Chen, K., Gautam, S., & Freedman, R. R. (2004). Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause, 11 (4), 375-381.
11. Carpenter, J. S., & Neal, J. G. (2005). Other complementary and alternative medicine modalities: Acupuncture, magnets, reflexology, and homeopathy. American Journal of Medicine, 118 (12, Suppl. 2), 109-117.
12. Charig, C. R., & Rundle, J. S. (1989). Flushing: Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology, 33 (3), 175-178.
13. Charkoudian, N. (2003). Skin blood flow in adult human thermoregulation: How it works, when it does not, and why. Mayo Clinic Proceedings, 78 (5), 603-612.
14. Clark, J. A., Wray, N. P., & Ashton, C. M. (2001). Living with treatment decisions: Regrets and quality of life among men treated for metastatic prostate cancer. Journal of Clinical Oncology, 19 (1), 72- 80.
15. Cooperberg, M. R., Small, E. J., D'Amico, A., & Carroll, P. R. (2003). The evolving role of androgen deprivation therapy in the management of prostate cancer. Minerva Urology and Nephrology, 55 (4), 219-238.
16. Curcio, J. J., Kim, L. S., Wollner, D., & Pockaj, B. A. (2005). The potential of 5-hydryoxytryptophan for hot flash reduction: A hypothesis. Alternative Medicine Review, 10 (3), 216-221.
17. Dacal, K., Sereika, S. M., & Greenspan, S. L. (2006). Quality of life in prostate cancer patients taking androgen deprivation therapy. Journal of the American Geriatric Society, 54 (1), 85-90.
18. Denis, L. (1993). Prostate cancer: Primary hormonal treatment. Cancer, 71 (3, Suppl.), 1050-1058.
19. Dormire, S. L., & Carpenter, J. S. (2002). An alternative to unibase/ glycol as an effective nonhydrating electrolyte medium for the measurement of electrodermal activity. Psychophysiology, 39 (4), 423-426.
20. Freedman, R. R. (1989). Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology, 26 (5), 573-579.
21. Freedman, R. R. (1998). Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertility and Sterility, 70 (2), 332-337.
22. Freedman, R. R. (2005). Hot flashes: Behavioral treatments, mechanisms, and relation to sleep. American Journal of Medicine, 118 (12, Suppl. 2), 124-130.
23. Freedman, R. R., & Dinsay, R. (2000). Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertility and Sterility, 74 (1), 20-23.
24. Freedman, R. R., & Krell, W. (1999). Reduced thermoregulatory null zone in postmenopausal women with hot flashes. American Journal of Obstetrics and Gynecology, 181 (1), 66-70.
25. Freedman, R. R., Norton, D., Woodward, S., & Cornelissen, G. (1995). Core body temperature and circadian rhythm of hot flashes in menopausal women. Journal of Clinical Endocrinology Metabolism, 80 (8), 2354-2358.
26. Frodin, T., Alund, G., & Varenhorst, E. (1985). Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patients with prostatic cancer. Prostate, 7 (2), 203-208.
27. Gitler, M. S., & Barraclough, C. A. (1987). Locus coeruleus (LC) stimulation augments LHRH release induced by medial preoptic stimulation: Evidence that the major (LC) stimulatory component enters contralaterally into the hypothalamus. Brain Research, 422 (1), 1-10.
28. Griffin, J. (2000). Male reproductive function. In Textbook of endocrine physiology (4th ed., pp. 243-255). New York: Oxford University Press.
29. Halasz, B., Kiss, J., & Molnar, J. (1989). Regulation of the gonadotropin-releasing hormone (GnRH) neuronal system: Morphological aspects. Journal of Steroid Biochemistry, 33, 663- 663.
30. Huggins, C., Stevens, R. E., Jr., & Hodges, C. V. (1941). Studies on prostate cancer: The effects of castration on advanced carcinoma of the prostate gland. Archives of Surgery, 43, 209-223.
31. Karling, P., Hammar, M., & Varenhorst, E. (1994). Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. Journal of Urology, 152 (4), 1170-1173.
32. Kronenberg, F. (1990). Hot flashes: Epidemiology and physiology. Annals of the New York Academy of Science, 592, 52-86; discussion, 123-133.
33. Kronenberg, F. (1994). Hot flashes: Phenomenology, quality of life, and search for treatment options. Experimental Gerontology, 29 (3-4), 319-336.
34. Labrie, F. (1993). Mechanism of action and pure antiandrogenic properties of flutamide. Cancer, 72 (12, Suppl.), 3816-3827.
35. Labrie, F. (2002). Androgen blockade in prostate cancer in 2002: Major benefits on survival in localized disease. Molecular and Cell Endocrinology, 198 (1-2), 77-87.
36. Labrie, F., Belanger, A., Simard, J., Labrie, C., & Dupont, A. (1993). Combination therapy for prostate cancer: Endocrine and biologic basis of its choice as new standard first-line therapy. Cancer, 71 (3, Suppl.), 1059-1067.
37. Lin, M. T., Tsay, H. J., Su, W. H., & Chueh, F. Y. (1998). Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. American Journal of Physiology, 274 (5), R1260-R1267.
38. Loprinzi, C., Michalak, J. C., Quella, S. K., O'Fallon, J. R., Hatfield, A. K., Nelimark, R. A., et al. (1994). Megestrol acetate for the prevention of hot flashes. New England Journal of Medicine, 331 (6), 347-352.
39. Loprinzi, C. L., Barton, D. L., Carpenter, L. A., Sloan, J. A., Novotny, P. J., Gettman, M. T., et al. (2004). Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clinic Proceedings, 79 (10), 1247-1251.
40. Loprinzi, C. L., Pisansky, T. M., Fonseca, R., Sloan, J. A., Zahasky, K. M., Quella, S. K., et al. (1998). Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. Journal of Clinical Oncology, 16 (7), 2377-2381.
41. McCullagh, D. R., & Walsh, E. L. (1935). Experimental hyper-trophy and atrophy of the prostate gland. Endocrinology, 19, 466-466.
42. Miller, H. G., & Li, R. M. (2004). Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clinic Proceedings, 79 (6), 777-781.
43. Mohyi, D., Tabassi, K., & Simon, J. (1997). Differential diagnosis of hot flashes. Maturitas, 27 (3), 203-214.
44. Molina, J. R., Barton, D. L., & Loprinzi, C. L. (2005). Chemotherapy-induced ovarian failure: Manifestations and management. Drug Safety, 28 (5), 401-416.
45. Naoe, M., Ogawa, Y., Shichijo, T., Fuji, K., Fukagai, T., & Yoshida, H. (in press). Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer. Prostate Cancer Prostatic Disease.
46. Pandya, K. J., Raubertas, R. F., Flynn, P. J., Hynes, H. E., Rosenbluth, R. J., Kirshner, J. J., et al. (2000). Oral cloni-dine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: A University of Rochester Cancer Center Community Clinical Oncology Program study. Annals of Internal Medicine, 132 (10), 788-793.
47. Parra, R. O., & Gregory, J. G. (1990). Treatment of post-orchiectomy hot flashes with transdermal administration of clonidine. Journal of Urology, 143 (4), 753-754.
48. Rosenberg, J., & Larsen, S. H. (1991). Hypothesis: Pathogenesis of postmenopausal hot flush. Medical Hypotheses, 35 (4), 349-350.
49. Savage, M. V., & Brengelmann, G. L. (1996). Control of skin blood flow in the neutral zone of human body temperature regulation. Journal of Applied Physiology, 80 (4), 1249-1257.
50. Schally, A. V. (1987). Treatment of hormone-dependent cancer with analogues of hypothalamic hormones: Experimental and clinical studies. Annals of the New York Academy of Science, 496, 602-607.
51. Schmitt, B., Bennett, C. L., Seidenfeld, J., Sampson, D., & Wilt, T. (2000). Maximal androgen blockade for advanced prostate cancer. Cochrane Database of Systematic Reviews, 2, CD001526.
52. Sipe, K., Leventhal, L., Burroughs, K., Cosmi, S., Johnston, G. H., & Deecher, D. C. (2004). Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Research, 1028 (2), 191-202.
53. Slopien, R., Meczekalski, B., & Warenik-Szymankiewicz, A. (2003). Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric, 6 (1), 53-57.
54. Small, E. J., Prins, G. S., & Taplin, M. E. (2000). The androgen receptor and the physiology and endocrinology of the prostate. In N. J. Vogelzang, P. T. Scardino, W. U. Shipley, & D. S. Coffey (Eds.), Comprehensive textbook of genitourinary oncology (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.
55. Smith, J. A., Jr. (1996). Management of hot flushes due to endocrine therapy for prostate carcinoma. Oncology (Williston Park), 10 (9), 1319-1322; discussion, 1324.
56. Spetz, A. C., Pettersson, B., Varenhorst, E., Theodorsson, E., Thorell, L. H., & Hammar, M. (2001). Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate. Journal of Urology, 166 (5), 1720-1723.
57. Stearns, V., Ullmer, L., Lopez, J. F., Smith, Y., Isaacs, C., & Hayes, D. (2002). Hot flushes. Lancet, 360 (9348), 1851-1861.
58. Stewart-Bentley, M., Odell, W. D., & Horton, R. (1974). The feedback control of luteinizing hormone. Journal of Clinical Endocrinology Metabolism, 38, 545- 545.
59. Veldhuis, J. D. (1999). Male hypothalamic-pituitary-gonadal axis. In S. E. Yen, R. B. Jaffe, & R. L. Barbieri (Eds.), Reproductive endocrinology: Physiology, pathophysiology, and clinical management (4th ed., pp. 622-631). Philadelphia: W. B. Saunders.
60. Vogelzang, N. J., Scardino, P. T., Shipley, W. U., & Coffey, D. S. (Eds.). (2000). Comprehensive textbook of genitourinary oncology (2nd ed.). Philadelphia: Lippincott Williams and Wilkins.
61. Walsh, B., & Schiff, I. (1990). Vasomotor flushes. Annals of the New York Academy of Science, 592, 346-356; discussion, 390-344.
62. Walsh, P. C., Retik, A. B., Vaughan, E. D., & Wein, A. J. (Eds.). (2002). Campbell's urology (8th ed.). Philadelphia: W. B. Saunders.
63. Walsh, P. C., Wein, A. J., Retik, A. B., & Vaughan, E. D. (Eds.). (1997). Campbell's urology (7th ed.). Philadelphia: W. B. Saunders.
64. Weldon, V. E., Neuwirth, H., & Bennett, P. M. (2005). Marin urology. Retrieved August 4, 2005, from http://www.marinurology.com/articles/cap/ learning/hormonal.htm
65. Wollesen, F., Swerdloff, R. S., & Odell, W. D. (1976). LH and FSH responses to luteinizing releasing hormones in normal adult males. Metabolism, 25, 1275-1275.
66. Ying, S. Y. (1988). Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocrine Review, 9, 267-267.
67. Yuzurihara, M., Ikarashi, Y., Noguchi, M., Kase, Y., Takeda, S., & Aburada, M. (2003). Involvement of calcitonin gene-related peptide in elevation of skin temperature in castrated male rats. Urology, 62 (5), 947-951.
68. Yuzurihara, M., Ikarashi, Y., Noguchi, M., Kase, Y., Takeda, S., & Aburada, M. (2004). Prevention by 17beta-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats. Urology, 64 (5), 1042- 1047.